English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduSimon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents’ questions
Tag: covid-19 pediatric trial
COVID-19 Vaccine Receives Emergency Use Authorization for Children Ages 5 to 11
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents’ questions
COVID-19 Vaccine Receives Emergency Use Authorization for Children Ages 5 to 11
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents’ questions
COVID-19 Vaccine Receives Emergency Use Authorization for Children Ages 5 to 11
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents’ questions
COVID-19 Vaccine Receives Emergency Use Authorization for Children Ages 5 to 11
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents’ questions
COVID-19 Vaccine Receives Emergency Use Authorization for Children Ages 5 to 11
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents’ questions
COVID-19 Vaccine Receives Emergency Use Authorization for Children Ages 5 to 11
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents’ questions
COVID-19 Vaccine Receives Emergency Use Authorization for Children Ages 5 to 11
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents’ questions
COVID-19 Vaccine Receives Emergency Use Authorization for Children Ages 5 to 11
Simon Li, a principal investigator in the Rutgers pediatric clinical trial for the Pfizer-BioNTech COVID-19 vaccine, addresses parents’ questions